SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2013. Upgrade now.
Date Value
March 31, 2024 4.862M
December 31, 2023 6.642M
September 30, 2023 5.859M
June 30, 2023 6.844M
March 31, 2023 7.357M
December 31, 2022 8.759M
September 30, 2022 8.149M
June 30, 2022 8.920M
March 31, 2022 7.905M
December 31, 2021 8.523M
September 30, 2021 8.066M
June 30, 2021 6.555M
March 31, 2021 5.406M
December 31, 2020 4.923M
September 30, 2020 4.040M
June 30, 2020 2.87M
March 31, 2020 3.89M
December 31, 2019 2.990M
September 30, 2019 3.102M
June 30, 2019 2.631M
March 31, 2019 2.765M
December 31, 2018 3.476M
September 30, 2018 2.778M
Date Value
June 30, 2018 2.584M
March 31, 2018 2.504M
December 31, 2017 2.232M
September 30, 2017 2.206M
June 30, 2017 2.166M
March 31, 2017 2.393M
December 31, 2016 2.248M
September 30, 2016 2.434M
June 30, 2016 2.22M
March 31, 2016 2.309M
December 31, 2015 2.140M
September 30, 2015 2.298M
June 30, 2015 1.852M
March 31, 2015 2.085M
December 31, 2014 2.181M
September 30, 2014 0.33M
June 30, 2014 -6.013M
March 31, 2014 6.487M
December 31, 2013 0.9284M
September 30, 2013 5.221M
June 30, 2013 1.962M
March 31, 2013 1.218M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

2.631M
Minimum
Jun 2019
8.920M
Maximum
Jun 2022
5.915M
Average
6.207M
Median

SG&A Expense (Quarterly) Benchmarks

CureVac NV 18.25M
InflaRx NV 5.473M
MorphoSys AG -9.867M
BioNTech SE 144.03M
Immatics NV 12.65M